| Line Item | 2023-12-30 | Y/Y |
|---|---|---|
| Revenue | $5.23B | +7.6% |
| Cost of Revenue | $2.22B | +8.3% |
| Gross Profit | $3.00B | +7.1% |
| R&D Expense | $904.7M | +8.4% |
| SG&A Expense | $835.0M | +7.6% |
| Operating Income | $1.09B | +6.3% |
| Pre-tax Income | $1.20B | +12.7% |
| Income Tax | -$89.3M | -197.7% |
| Net Income | $1.29B |
| Line Item | 2023-12-30 | Y/Y |
|---|---|---|
| Cash & Equivalents | $1.69B | +32.4% |
| Accounts Receivable | $815.2M | +24.1% |
| Inventory | $1.35B | -11.2% |
| Current Assets | $4.46B | +12.9% |
| Total Assets | $8.60B | +11.3% |
| Current Liabilities | $1.31B | +8.2% |
| Stockholders' Equity | $7.01B | +13.0% |
| Line Item | 2023-12-30 | Y/Y |
|---|---|---|
| Operating Cash Flow | $1.38B | +74.6% |
| Capital Expenditures | $193.5M | -20.8% |
| Investing Cash Flow | -$333.0M | -129.4% |
| Financing Cash Flow | -$636.5M | +24.3% |
| Free Cash Flow | $1.18B | +117.4% |
| +32.5% |
| EPS (Basic) | $6.74 | +33.2% |
| EPS (Diluted) | $6.71 | +33.1% |